First National Corp’s Exelon EXC Stock Holding History

First National Corp’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,988	Closed	-$206K	–	146
2019 Q3	$206K	Hold	5,988	–	–	0.08%	140
2019 Q2	$205K	Hold	5,988	–	–	0.08%	135
2019 Q1	$214K	Hold	5,988	–	–	0.09%	132
2018 Q4	$193K	Buy	+5,988	New	+$192K	0.09%	136

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First National Corp's EXC Position: Q4 2019 in Review

First National Corp sold out of Exelon (EXC) in Q4 2019, closing a stake of 5,988 shares — an estimated $206K sold.

First National Corp first reported a position in EXC in Q4 2018 and held it in 4 quarters. The position peaked at $214K in Q1 2019. 970 funds tracked by Wall St. Rank hold EXC as of Q4 2019.

First National Corp reported no remaining Exelon position as of Q4 2019 after selling out during the quarter.
First National Corp sold 5,988 Exelon shares in Q4 2019, an estimated $206K.
First National Corp first reported a position in Exelon in Q4 2018 and held it in 4 quarters.
First National Corp's Exelon position peaked at $214K in Q1 2019.
970 funds tracked by Wall St. Rank held Exelon as of Q4 2019.

Based on First National Corp's 13F filing for Q4 2019, filed 31 Jan 2020.